Back

12-month outcomes following multidisciplinary management of postural orthostatic tachycardia syndrome (POTS)

30 August 2026 (10:18 - 10:30)
Organised by: Logo
Congress Presentation Part of: Optimising cardiovascular care delivery: acute complications, treatment pathways, and sustained patient adherence Chronic Nursing Care ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Gemma Wilson

University of Adelaide, Adelaide (Australia)

4 More presentations in this session

Presentation thumbnail
A nurse-delivered analgesia pathway for severe pain reduction during radial access
Miss J. Gomez Carrillo (Murcia, ES)
Abstract Slides Video
Presentation thumbnail
More than one in four patients hospitalised for coronary artery disease report high medication concerns: findings from a multicentre observational cohort study
Ms D. Schaminee (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Home-based cardiac rehabilitation for people living with heart failure the DK: REACH-HF pilot study
Mrs M. Hansen (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Long term adherence to prescribed cardiovascular medications in patients after percutaneous coronary intervention
Doctor T. Pettersen (Bergen, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising cardiovascular care delivery: acute complications, treatment pathways, and sustained patient adherence
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 10:18 CET
You may be interested in
thumbnail
Congress Presentation
Living with postural orthostatic tachycardia syndrome: a patient perspective
1 April 2025
thumbnail
Congress Presentation
Long-term outcomes in Tetralogy of Fallot: from the australian national congenital heart disease registry
28 August 2026
thumbnail
Congress Session
Syncope and conduction disturbances: new scientific evidence
25 August 2023
thumbnail
Congress Presentation
Treatment of Post-COVID-19 POTS by inhibiting FcRn: a phase 2 randomized, placebo controlled, double-blind, proof of concept study with efgartigimod
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources